v3.26.1
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 2 $ 14 $ 5 $ 33
General and administrative 1,044 1,534 2,333 3,362
Total operating expenses 1,046 1,548 2,338 3,395
Loss from operations (1,046) (1,548) (2,338) (3,395)
Other income (expense):        
Interest income 10 41 22 94
Fair value adjustment of warrants 1 67
Other income (expense), net (43) 108 (123)
Total other income (expense), net 10 (1) 130 38
Net loss (1,036) (1,549) (2,208) (3,357)
Dividends accrued on Series B Convertible Preferred Stock (16) (16)
Net loss attributable to common stockholders $ (1,052) $ (1,549) $ (2,224) $ (3,357)
Net loss per share attributable to common stockholders - basic $ (0.29) $ (0.42) $ (0.61) $ (0.92)
Net loss per share attributable to common stockholders - diluted $ (0.29) $ (0.42) $ (0.61) $ (0.92)
Weighted average common shares outstanding - basic 3,652,285 3,652,285 3,652,285 3,652,285
Weighted average common shares outstanding - diluted 3,652,285 3,652,285 3,652,285 3,652,285